I want to know the answer to the following question:
Who argued that drug regulators were greater serving the interests of the drug companies than the patients?
All the background I'm provided with is that "Ben Goldacre has argued that regulators – such as the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, or the Food and Drug Administration (FDA) in the United States – advance the interests of the drug companies rather than the interests of the public due to revolving door exchange of employees between the regulator and the companies and friendships develop between regulator and company employees.". Is that enough to answer the question?
Answer: yes